Skip to main content
. 2014 Dec 7;20(45):17227–17234. doi: 10.3748/wjg.v20.i45.17227

Table 2.

Outcomes of the combination therapy and transcatheter arterial chemoembolization alone groups

Ref. Year 1-yr survival
2-yr survival
3-yr survival
TACE + 3D-CRT TACE alone TACE + 3D-CRT TACE alone TACE + 3D-CRT TACE alone
Chia-Hsien Cheng et al[25] 2001 58.0% 56.0%
Lan et al[24] 2005 57.1% 61.7% 40.5% 30.0% 26.2% 16.7%
Li et al[23] 2003 73.2% 54.8% 58.7% 27.3% 41.9% 12.8%
Liao et al[22] 2010 74.0% 50.0% 30.0% 14.0%
Liu et al[21] 2005 66.5% 53.9% 48.4% 37.2% 37.4% 17.8%
Shang et al[20] 2007 78.0% 50.0% 60.0% 32.0% 34.0% 18.0%
Shim et al[19] 2005 36.8% 14.3%
Wu et al[18] 2004 90.2% 89.7% 75.6% 58.7% 44.6% 24.0%
Zeng et al[17] 2004 71.5% 59.6% 42.3% 26.5% 24.0% 11.1%
Zhao et al[16] 2006 82.0% 55.0% 63.0% 28.0% 43.0% 15.0%

TACE: Transcatheter arterial chemoembolization; 3D-CRT: Three-dimensional conformal radiotherapy.